Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Heylmann, Daniel; Badura, Jennifer; Becker, Huong et al.
Sensitivity of CD3/CD28-stimulated versus non-stimulated lymphocytes to ionizing radiation and genotoxic anticancer drugs: key role of ATM in the differential radiation responseCELL DEATH & DISEASE. Bd. 9. 2018
Steigerwald, C.; Rasenberger, B.; Kaina, B. et al.
Sensitization of colorectal cancer cells to topoisomerase I Inhibitors via pharmacological inhibition of IAPsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 391. 2018 S. S58-S58
Best, J.; Bechmann, L.; Dechene, A. et al.
Serological diagnosis of early HCC in NASH: A German multicenter studyJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S421-S422
Gerlach, Christina; Pretzell, Ina; Lieberknecht, Elisabeth et al.
Severe Pain Due to Paraspinal Abscess Formation in Two Patients with Squamous-Cell Carcinoma of the Head and Neck after Multimodal Treatment Including CetuximabONCOLOGY RESEARCH AND TREATMENT. Bd. 41. H. 6. 2018 S. 395-398
Feiten, Stefan; Scholl, Isabelle; Schmidt, Marcus et al.
Shared decision making (SDM) in routine care treatment of breast cancer patients - a survey of patients following surgeryCANCER RESEARCH. Bd. 78. H. 4. 2018
Kumar, Abhishek; Cherukumilli, Madhuri; Mahmoudpour, Seyed Hamidreza et al.
ShRNA-mediated knock-down of CXCL8 inhibits tumor growth in colorectal liver metastasisBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 500. H. 3. 2018 S. 731-737
Bartlett, John M. S.; Thomas, Jeremy; Mallon, Elizabeth et al.
Simplified histological grading of breast carcinoma - potential for improved concordance and consistency in breast cancer grading?CANCER RESEARCH. Bd. 78. H. 4. 2018
Kuemmel, Andreas; Alflen, Astrid; Schmidt, Lars Henning et al.
Soluble Triggering Receptor Expressed on Myeloid Cells 1 in lung cancerSCIENTIFIC REPORTS. Bd. 8. 2018
Chekerov, Radoslav; Hilpert, Felix; Mahner, Sven et al.
Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialLANCET ONCOLOGY. Bd. 19. H. 9. 2018 S. 1247-1258
Mathew, Nimitha R.; Baumgartner, Francis; Braun, Lukas et al.
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cellsNATURE MEDICINE. Bd. 24. H. 3. 2018 S. 282-+